Trademark: 88303631
Word
3P BIOPHARMACEUTICALS
Status Date
Monday, December 19, 2022
Filing Date
Friday, February 15, 2019
Published for Opposition
Tuesday, February 2, 2021
Abandoned Date
Thursday, December 8, 2022
5 Biopharmaceutical preparations for medical purposes, namely, monoclonal antibodies for use in vaccines, therapy, diagnosis and research, biotechnological origin antibodies for use in therapy, diagnosis and research, antibody fragments for use in therapy, diagnosis and research, fused antibody fragments for use in therapy, diagnosis and research, conjugated antibodies for use in therapy, diagnosis and research, engineered antibodies for use in therapy, diagnosis and research, vaccines and natural biomaterials for augmentation of bone and tissue, biotechnological scaffolds for cell therapy products and controlled released drugs, synthetic protein scaffolds, engineered antibodies scaffolds, non-antibody binding proteins for pharmaceutical and industrial applications, proteins for pharmaceuticals and industrial applications
The mark consists of the wording "3P" with "3" in pink and the "P" in fuchsia. To the left is a fuchsia curved line design forming a "3" superimposed over the letter "P", with the word "BIOPHARMACEUTICALS" in fuchsia in vertical form to the left of the design.
THREE P BIO PHARMACEUTICALS
The color(s) fuchsia and pink is/are claimed as a feature of the mark.
"BIOPHARMACEUTICALS"
Dec 19, 2022
Abandonment Notice E-Mailed - Failure To Respond
Dec 19, 2022
Abandonment Notice Mailed - Failure To Respond
Dec 19, 2022
Abandonment - Failure To Respond Or Late Response
Jun 7, 2022
Notification Of Non-Final Action E-Mailed
Jun 7, 2022
Non-Final Action E-Mailed
Jun 7, 2022
Su - Non-Final Action - Written
May 12, 2022
Teas/Email Correspondence Entered
May 12, 2022
Correspondence Received In Law Office
May 6, 2022
Teas Response To Office Action Received
Nov 8, 2021
Notification Of Non-Final Action E-Mailed
Nov 8, 2021
Non-Final Action E-Mailed
Nov 8, 2021
Su - Non-Final Action - Written
Oct 12, 2021
Statement Of Use Processing Complete
Sep 28, 2021
Use Amendment Filed
Oct 12, 2021
Case Assigned To Intent To Use Paralegal
Sep 28, 2021
Teas Statement Of Use Received
Mar 30, 2021
Noa E-Mailed - Sou Required From Applicant
Feb 2, 2021
Official Gazette Publication Confirmation E-Mailed
Feb 2, 2021
Published For Opposition
Jan 13, 2021
Notification Of Notice Of Publication E-Mailed
Dec 29, 2020
Approved For Pub - Principal Register
Dec 29, 2020
Examiner's Amendment Entered
Dec 29, 2020
Notification Of Examiners Amendment E-Mailed
Dec 29, 2020
Examiners Amendment E-Mailed
Dec 29, 2020
Examiners Amendment -Written
Jul 9, 2020
Notification Of Final Refusal Emailed
Jul 9, 2020
Final Refusal E-Mailed
Jul 9, 2020
Final Refusal Written
Jun 13, 2020
Teas/Email Correspondence Entered
Jun 13, 2020
Correspondence Received In Law Office
Jun 11, 2020
Assigned To Lie
Jun 4, 2020
Teas Response To Office Action Received
Dec 4, 2019
Notification Of Non-Final Action E-Mailed
Dec 4, 2019
Non-Final Action E-Mailed
Dec 4, 2019
Non-Final Action Written
Nov 7, 2019
Teas/Email Correspondence Entered
Nov 7, 2019
Correspondence Received In Law Office
Nov 7, 2019
Teas Response To Office Action Received
May 8, 2019
Notification Of Non-Final Action E-Mailed
May 8, 2019
Non-Final Action E-Mailed
May 8, 2019
Non-Final Action Written
Apr 27, 2019
Assigned To Examiner
Mar 21, 2019
Notice Of Design Search Code E-Mailed
Mar 8, 2019
New Application Office Supplied Data Entered
Feb 19, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
